Key result
Multimodal therapy including chemotherapy, limited mastectomy, and radiation resulted in a >50% reduction in tumor size in 77% of women with stage III breast cancer.
Why the study?
Does multimodal therapy including neoadjuvant chemotherapy, surgery, and postoperative chemoradiation reduce tumor size and recurrence in women with stage III breast cancer?
Cohort (n=31)
Does multimodal therapy including neoadjuvant chemotherapy, surgery, and postoperative chemoradiation reduce tumor size and recurrence in women with stage III breast cancer?
Answers are grounded in this paper and cite their sources.
Multimodal therapy including neoadjuvant chemotherapy is effective in reducing primary tumor size in stage III breast cancer, allowing for limited mastectomy with minimal morbidity.
Thirty-one women with stage III breast cancer were prospectively treated with two cycles of cyclophosphamide (Cytoxan), doxorubicin hydrochloride (Adriamycin), fluorouracil, and tamoxifen citrate followed by a simple mastectomy with level I axillary dissection. Postoperatively, four additional cycles of the combination chemotherapy alternating with three cycles of 1500 rad (15 Gy) to the chest wall and lymphatics were given. Seventy-seven percent of patients had a greater than 50% reduction in tumor size after the initial chemotherapy. No tumor size progressed during therapy, and a single patient remained inoperable. Pathologic findings revealed nine patients with only microscopic residual tumor. Nuclear vacuolization was present in 42.8% of tumor cells after chemotherapy vs 14.2% of cells before chemotherapy. The mean follow-up for the groups is 24.3 months. To date, nine patients have had recurrence with only one isolated local recurrence. This therapy is effective in reducing primary tumor size and allows a limited mastectomy to be done with minimal morbidity.
No takes yet. Share an insight, caveat, or question.
Monica Morrow (1986) conducted a cohort in Stage III breast cancer (n=31). Multimodal therapy (cyclophosphamide, doxorubicin, fluorouracil, tamoxifen, mastectomy, and radiation) was evaluated on >50% reduction in tumor size after initial chemotherapy. Multimodal therapy including chemotherapy, limited mastectomy, and radiation resulted in a >50% reduction in tumor size in 77% of women with stage III breast cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: